Carregant...
Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
In patients with rheumatic diseases undergoing immunosuppressive treatment, hepatitis B virus reactivation (HBVr) has been long recognized as a major treatment-related adverse event with substantial morbidity and mortality. Because HBVr is easily preventable with appropriate screening and monitoring...
Guardat en:
| Publicat a: | Ther Adv Musculoskelet Dis |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7076579/ https://ncbi.nlm.nih.gov/pubmed/32206094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20912646 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|